ROR1 and cancer: Among the common receptor tyrosine kinase (RTK)-relevant pathways, FGFR pathways are the most commonly enriched pathways in ROR1-high cancer specimens, following with platelet-derived growth factor receptor (PDGFR) (Figure 4b).